Association of Medical Microbiology
and Infectious Disease Canada

l’Association pour la microbiologie
médicale et l’infectiologie Canada



Association of Medical Microbiology
and Infectious Disease Canada

l’Association pour la microbiologie
médicale et l’infectiologie Canada


Antimicrobial Stewardship and Resistance
Canadian Antimicrobial Resistance Surveillance System (CARSS)

The Canadian Antimicrobial Resistance Surveillance System (CARSS) Report – 2020 is now available on the Government of Canada website.

The CARSS report provides an integrated picture of antimicrobial resistance (AMR) and antimicrobial use (AMU) in Canada, prioritizing data acquired by the Public Health Agency of Canada (PHAC) and its partners. Web links to this year’s report will be circulated shortly.

This year’s report provides details on AMR in organisms of highest concern to Canadians, as well as information on AMU in human and animal populations. In summary:

  • There are indications that the AMR landscape is worsening in humans.
  • AMU continues to increase in humans, particularly in elderly Canadians.
  • Despite overall declines, the quantities of antimicrobials sold for use in animals increased between 2017 and 2018.

The growing trend of AMR is a problem that no entity can solve on its own. We look forward to the continued and improved integration of AMR and AMU data from all PHAC partners, as we collaboratively work towards limiting the rise of AMR infections in Canada.


Chief Public Health Officer (CPHO)

Chief Public Health Officer of Canada spotlight report on Handle with Care: Preserving Antibiotics Now and Into the Future.

This report highlights the social and cultural drivers of the unnecessary prescribing and improper use of antibiotics in Canada and describes what Canadians, health care providers, and health system leaders can do to reduce inappropriate antibiotic use and conserve their effectiveness.

National Advisory Committee on Immunization (NACI)

National Advisory Committee on Immunization (NACI): Statements and publications

NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable diseases for whom vaccination should be targeted. NACI knowledge syntheses, analyses and recommendations on vaccine use in Canada are published in literature reviews, statements and updates.
New statements are those which have been published within the past five years. Previous statements are those which are were published over five years ago and have been archived.

NACI recommendations are also published in vaccine-specific chapters of the Canadian Immunization Guide.

Email updates are available through our mailing list. To subscribe to receive instant alerts when chapter updates and new NACI products are posted.

Novel Coronavirus
Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Facebook Posts

2 weeks ago
AMMI Canada

It is Antimicrobial Awareness Week! As a reminder to Handle with Care, we are highlighting the AMMI Canada Position Statement on antimicrobial resistance.

“Antimicrobials (which include antibiotics) are a precious public resource and an essential tool for fighting infections in both humans and animals.

Their importance to human medical, nutritional, and economic security cannot be understated.

Yet globally, antimicrobials are losing their effectiveness more quickly than new antimicrobial drugs, treatments, and therapies are being identified and introduced to market.”

Spread Awareness, Stop Resistance. Read more:

#antibiotics #antimicrobial #AntimicrobialAwarenessWeek #antimicrobialawarenessweek2021 #antivirals #awareness #handlewithcare #spreadawareness #StopResistance #resistance #WAAW2021
... See MoreSee Less

Load more